http://www.unboundmedicine.com/medline/ebm/research/insulin_aspartUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19854333/full_citation/A_1c__control_in_a_primary_care_setting:_self_titrating_an_insulin_analog_pre_mix__INITIATEplus_trial__Oyer DS, Shepherd MD, Coulter FC, et al. 
A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). [Journal Article, Research Support, Non-U.S. Gov't]
Am J Med 2009 Nov; 122(11):1043-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19850703/full_citation/Three_year_efficacy_of_complex_insulin_regimens_in_type_2_diabetes_Holman RR, Farmer AJ, Davies MJ, et al. 
Three-year efficacy of complex insulin regimens in type 2 diabetes. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
N Engl J Med 2009 Oct 29; 361(18):1736-47.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19848574/full_citation/Time_Action_Profile_and_Patient_Assessment_of_Inhaled_Insulin_via_the_Exubera_Device_in_Comparison_with_Subcutaneously_Injected_Insulin_Aspart_via_the_FlexPen_Device_Forst T, Hohberg C, Schöndorf T, et al. 
Time-Action Profile and Patient Assessment of Inhaled Insulin via the Exubera Device in Comparison with Subcutaneously Injected Insulin Aspart via the FlexPen Device. [Journal Article]
Diabetes Technol Ther 2009 Feb; 11(2):87-92.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19826097/full_citation/Sliding_Scale_Versus_Tight_Glycemic_Control_in_the_Noncritically_Ill_at_a_Community_Hospital_November__Patel GW, Roderman N, Lee KA, et al. 
Sliding Scale Versus Tight Glycemic Control in the Noncritically Ill at a Community Hospital(November). [JOURNAL ARTICLE]
Ann Pharmacother 2009 Oct 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19825323/full_citation/Leukocytoclastic_vasculitis_associated_with_insulin_aspart_in_a_patient_with_Type_2_diabetes_Marusic S, Vlahovic-Palcevski V, Ljubanovic D 
Leukocytoclastic vasculitis associated with insulin aspart in a patient with Type 2 diabetes. [Journal Article]
Int J Clin Pharmacol Ther 2009 Oct; 47(10):603-5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19821654/full_citation/Once_daily_initiation_with_biphasic_insulin_aspart_30_versus_insulin_glargine_in_patients_with_type_2_diabetes_inadequately_controlled_with_oral_drugs:_an_open_label_multinational_RCT_Strojek K, Bebakar WM, Khutsoane DT, et al. 
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19811109/full_citation/Examining_and_interpreting_responsiveness_of_the_Diabetes_Medication_Satisfaction_measure_Brod M, Christensen T, Kongsø JH, et al. 
Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure. [JOURNAL ARTICLE]
J Med Econ 2009 Oct 8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19808125/full_citation/Risk_for_nocturnal_hypoglycemia_with_biphasic_insulin_aspart_30_compared_with_biphasic_human_insulin_30_in_adults_with_type_2_diabetes_mellitus:_a_meta_analysis_Davidson JA, Liebl A, Christiansen JS, et al. 
Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. [Journal Article]
Clin Ther 2009 Aug; 31(8):1641-51.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19798455/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Jul-Aug; 31(6):397-417.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19783767/full_citation/Comparative_device_assessments:_Humalog_KwikPen_compared_with_vial_and_syringe_and_FlexPen_Ignaut DA, Schwartz SL, Sarwat S, et al. 
Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. [Journal Article, Research Support, Non-U.S. Gov't]
Diabetes Educ 2009 Sep-Oct; 35(5):789-98.
Abstract | Full Citation